Evidence map›Paper›PMID 31515968›Full record

ArticleFEBS open bio2020

LncRNA DANCR promotes proliferation and metastasis in pancreatic cancer by regulating miRNA-33b.

Yongyun Luo, Qi Wang, Lili Teng, Jie Zhang, Jianjun Song, Wenping Bo, Di Liu, Yaqin He, Airong Tan

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Unraveling the therapeutic landscape of miRNAs in pancreatic cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. miRNAs in pancreatic cancer progression and metastasis.Clinical & experimental metastasis · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. LncRNAJournal of thoracic disease · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yongyun LuoDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Qi WangDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Lili TengDepartment of Geriatric Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Jie ZhangMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, China.
Jianjun SongDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Wenping BoDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Di LiuDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Yaqin HeMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, China.ORCID 0000-0001-6024-171X
Airong TanThird Department of Oncology, Qingdao Municipal Hospital (East Campus), Qingdao, China.
Ningxia Medical University · CNQingdao University · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence indicates that long noncoding RNAs (lncRNAs) function as important regulators in biological processes and are dysregulated in various tumors. The lncRNA DANCR functions as an oncogene in various cancers, but elucidation of its role in pancreatic cancer (PC) requires further investigation. In the current study, we demonstrate that DANCR was increased in PC tissues and cell lines. Knockdown of DANCR significantly suppressed cell proliferation, migration, and invasion and influenced the levels of epithelial-to-mesenchymal transition-associated proteins, as demonstrated by the observation of enhanced E-cadherin levels and reduced N-cadherin levels in PC cells. In addition, we identified direct binding to the predicted miR-33b binding site on DANCR. We also showed that there is reciprocal repression between DANCR and miR-33b. Furthermore, a miR-33b inhibitor partially abrogated knockdown of DANCR and caused inhibitory effects. We also demonstrated that DANCR functions as a miR-33b sponge to positively regulate MMP16 expression in PC cells. Collectively, the data reveal that DANCR exerts its function by regulating miR-33b/MMP16 expression, implying an important role for a lncRNA-miRNA-mRNA functional network and suggesting a novel potential therapeutic target for PC.

Indexed as

Cell ProliferationCell SurvivalHumansMicroRNAsPancreatic NeoplasmsRNA, Long NoncodingTumor Cells, CulturedDANCR long noncoding RNA, humanMicroRNAsMIRN33a microRNA, humanRNA, Long Noncodingcell proliferationlncRNA DANCRmetastasismiR-33bpancreatic cancer

Identifiers

PMID31515968
PMCPMC6943224
OpenAlexW2972489138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.